Praxis Precision Medicines, Inc. (PRAX) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $330.59 (+3.74%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jan 5, 2026 | Ami Fadia | Needham | $460.00 | +39.1% |
| Dec 15, 2025 | Jay Olson | Oppenheimer | $750.00 | +126.9% |
| Dec 9, 2025 | Yatin Suneja | Guggenheim | $760.00 | +129.9% |
| Dec 8, 2025 | Kambiz Yazdi | BTIG | $507.00 | +53.4% |
| Dec 5, 2025 | Yasmeen Rahimi | Piper Sandler | $450.00 | +36.1% |
| Dec 5, 2025 | Ami Fadia | Needham | $304.00 | -8.0% |
| Nov 6, 2025 | Yatin Suneja | Guggenheim | $540.00 | +63.3% |
| Oct 16, 2025 | Andrew Tsai | Jefferies | $300.00 | -9.3% |
| Jun 2, 2025 | Jay Olson | Oppenheimer | $97.00 | -70.7% |
| Sep 4, 2024 | Douglas Tsao | H.C. Wainwright | $60.30 | -81.8% |
| Sep 4, 2024 | Ami Fadia | Needham | $75.90 | -77.0% |
| Sep 3, 2024 | Francois Brisebois | Oppenheimer | $71.85 | -78.3% |
| Sep 3, 2024 | Joon Lee | Truist Financial | $75.38 | -77.2% |
| Aug 14, 2024 | Ami Fadia | Needham | $72.90 | -77.9% |
| Aug 14, 2024 | Yatin Suneja | Guggenheim | $85.43 | -74.2% |
| Aug 5, 2024 | Francois Brisebois | Oppenheimer | $67.35 | -79.6% |
| May 28, 2024 | Kambiz Yazdi | Jefferies | $70.88 | -78.6% |
| Mar 26, 2024 | Kambiz Yazdi | Jefferies | $64.35 | -80.5% |
Top Analysts Covering PRAX
PRAX vs Sector & Market
| Metric | PRAX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.32 | 2.24 | 2.41 |
| Analyst Count | 28 | 8 | 18 |
| Target Upside | +64.7% | +1150.2% | +14.9% |
| P/E Ratio | -23.89 | 6.89 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1M | $6M | $23M | 12 |
| 2027-03-31 | $11M | $11M | $11M | 4 |
| 2027-06-30 | $26M | $26M | $26M | 3 |
| 2027-09-30 | $56M | $56M | $56M | 3 |
| 2027-12-31 | $132M | $132M | $132M | 3 |
| 2028-03-31 | $5M | $5M | $5M | 2 |
| 2028-06-30 | $6M | $6M | $6M | 5 |
| 2028-09-30 | $7M | $7M | $7M | 4 |
| 2028-12-31 | $8M | $8M | $8M | 4 |
| 2029-12-31 | $799M | $2.22B | $4.17B | 9 |
| 2030-12-31 | $1.28B | $3.56B | $6.69B | 13 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-22.31 | $-14.98 | $-13.11 | 13 |
| 2027-03-31 | $-3.96 | $-3.96 | $-3.96 | 3 |
| 2027-06-30 | $-3.70 | $-3.70 | $-3.70 | 3 |
| 2027-09-30 | $-3.07 | $-3.07 | $-3.07 | 4 |
| 2027-12-31 | $-1.19 | $-1.19 | $-1.19 | 3 |
| 2028-03-31 | $0.00 | $0.00 | $0.00 | 4 |
| 2028-06-30 | $0.00 | $0.00 | $0.00 | 4 |
| 2028-09-30 | $0.00 | $0.00 | $0.00 | 6 |
| 2028-12-31 | $0.00 | $0.00 | $0.00 | 4 |
| 2029-12-31 | $5.81 | $34.53 | $74.02 | 8 |
| 2030-12-31 | $10.13 | $60.23 | $129.11 | 12 |
Frequently Asked Questions
What is the analyst consensus for PRAX?
The consensus among 28 analysts covering Praxis Precision Medicines, Inc. (PRAX) is Buy with an average price target of $544.40.
What is the highest price target for PRAX?
The highest price target for PRAX is $760.00, set by Yatin Suneja at Guggenheim on 2025-12-09.
What is the lowest price target for PRAX?
The lowest price target for PRAX is $60.30, set by Douglas Tsao at H.C. Wainwright on 2024-09-04.
How many analysts cover PRAX?
28 analysts have issued ratings for Praxis Precision Medicines, Inc. in the past 12 months.
Is PRAX a buy or sell right now?
Based on 28 analyst ratings, PRAX has a consensus rating of Buy (2.32/5) with a +64.7% upside to the consensus target of $544.40.
What are the earnings estimates for PRAX?
Analysts estimate PRAX will report EPS of $-14.98 for the period ending 2026-12-31, with revenue estimated at $6M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.